OpenVSafe by OpenVAERS
Search V-safe

FH2-17138-67707

2 vaccinations 9 coded responses 23 check-ins 9 free-text entries 2 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
386 / MS
Registered
2021-03-05
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-05
    Registered in v-safe
  2. 2021-03-05
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-05
    Survey response — day 0, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-06
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-07
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-08
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-09
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-12
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-19
    Survey response — day 14, dose 1
    MedDRA: Dyspnoea, Sluggishness — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Having some shortness of breath that may be related to allergies. Daily activities are about the same; may be a little sluggish from the OTC medication.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-26
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  14. 2021-03-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  15. 2021-03-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-03-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  17. 2021-04-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-02
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-09
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-16
    Survey response — day 21, dose 2
    MedDRA: Skin irritation, Urticaria — Feeling: Good
    Free text: Yes, Ive had welts on my neck and back this week and the previous week. They are not bothersome unless I wear clothing that rubs the areas. Ill keep watch on these areas to determine if I will seek medical attention.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-23
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-30
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-07
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-25
    Survey response — 3 months, dose 2
    MedDRA: Gout, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Ive suddenly developed gout in my foot. I have no family history and eat a fairly balanced diet. · Healthcare visit (other): Office visit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-06-25
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-07-01
  27. 2021-07-21
    Call successful
    Participant prefers to complete VAERS report online
  28. 2021-09-26
    Survey response — 6 months, dose 2
    MedDRA: Breakthrough COVID-19, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: I had a breakthrough case of COVID-19 and tested positive on 8/24/2021.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-09-26
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  30. 2021-09-28
  31. 2022-03-26
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-05Pfizer-BioNTech
22021-03-26Pfizer-BioNTech

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 5 — day 0, dose 1

2021-03-05

Systemic reaction (other): No

Release 5 — days 1–6 daily, dose 1

2021-03-06

Systemic reaction (other): None

2021-03-07

Systemic reaction (other): No

2021-03-08

Systemic reaction (other): No

2021-03-09

Systemic reaction (other): No

Release 5 — day 14, dose 1

2021-03-19

Symptoms: Having some shortness of breath that may be related to allergies. Daily activities are about the same; may be a little sluggish from the OTC medication.

Release 7 — day 21, dose 2

2021-04-16

Symptoms: Yes, Ive had welts on my neck and back this week and the previous week. They are not bothersome unless I wear clothing that rubs the areas. Ill keep watch on these areas to determine if I will seek medical attention.

Release 9 — 3 months, dose 2

2021-06-25

Symptoms: Ive suddenly developed gout in my foot. I have no family history and eat a fairly balanced diet.
Healthcare visit (other): Office visit

Release 9 — 6 months, dose 2

2021-09-26

Symptoms: I had a breakthrough case of COVID-19 and tested positive on 8/24/2021.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDBreakthrough COVID-19 · · ✓
SDDyspnoea ✓ ✓ ✓
SDGout ✓ ✓ ✓
SDSARS-CoV-2 test positive · · ✓
SDSkin irritation ✓ ✓ ✓
SDSluggishness ✓ ✓ ✓
SDUrticaria ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release